Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date

por Iyer, Sunil Girish, Stanchina, Michele, Bradley, Terrence J, Watts, Justin
Publicado 2022

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products

por Nguyen, Nina, Madarang, Ellen, Alencar, Alvaro, Watts, Justin, Bradley, Terrence
Publicado 2022

Spontaneous remission of acute myeloid leukemia with NF1 alteration

por Bradley, Terrence, Zuquello, Radames Adamo, Aguirre, Luis E., Mackrides, Nicholas, Chapman, Jennifer, Cimmino, Luisa, Thomassen, Amber, Watts, Justin
Publicado 2020

Molecular characteristics and outcomes in Hispanic and non‐Hispanic patients with acute myeloid leukemia

por Bradley, Terrence, Kwon, Deukwoo, Monge, Jorge, Sekeres, Mikkael, Chandhok, Namrata, Thomassen, Amber, Swords, Ronan, Padron, Eric, Lancet, Jeff, Talati, Chetasi, Watts, Justin
Publicado 2022

Discordance Between Radiologic Findings and Molecular Testing in Patients With Underlying Hematologic Malignancy and Coronavirus Disease 2019

por Raja, Mohammed, Natori, Yoichiro, Chandorkar, Aditya, Camargo, Jose F, Simkins, Jacques, Andrews, David, Bradley, Terrence, Watts, Justin, Komanduri, Krishna, Morris, Michele I, Fishman, Joel E
Publicado 2020

PB2221: AN OPEN-LABEL, PHASE 1/1B STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL ACTIVITY OF IMETELSTAT IN COMBINATION WITH RUXOLITINIB IN PATIENTS W...

por Kuykendall, Andrew, Bradley, Terrence, Komrokji, Rami S., Berry, Tymara, Dougherty, Souria, Sherman, Laurie, Peng, Lixian, Huang, Fei, Wan, Ying, Rodolf, Vivian, Ho, Judy, Navada, Shyamala, Mascarenhas, John
Publicado 2023

P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA

por Lech-Marańda, Ewa, Szymańska, Agata, Zaucha, Jan, Borthakur, Gautam, Solomon, Scott, Bradley, Terrence, Mouhayar, Elie, Angelosanto, Noemi, Nogai, Hendrik, Brzozka, Krzysztof, Rzymski, Tomasz, Littlewood, Peter, Kus, Kamil, Dudziak, Renata, Glasmacher, Axel, Burris, Howard, Abboud, Camille
Publicado 2023

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)

por Nguyen, Nina, Chaudhry, Sana, Totiger, Tulasigeri M., Diaz, Robert, Roberts, Evan, Montoya, Skye, Pardo, Gabriel, Pardo, Alejandro, Afaghani, Jumana, Affer, Maurizio, Jahn, Jacob, Bradley, Terrence, Maura, Francesco, Kazandjian, Dickran, Bilbao, Daniel, Chapman, Jennifer, Landgren, Ola, Hoffman, James, Taylor, Justin
Publicado 2022

Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia

por Daver, Naval, Perl, Alexander E., Maly, Joseph, Levis, Mark, Ritchie, Ellen, Litzow, Mark, McCloskey, James, Smith, Catherine C., Schiller, Gary, Bradley, Terrence, Tiu, Ramon V., Naqvi, Kiran, Dail, Monique, Brackman, Deanna, Siddani, Satya, Wang, Jing, Chyla, Brenda, Lee, Paul, Altman, Jessica K.
Publicado 2022

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results

por Daver, Naval G., Vyas, Paresh, Kambhampati, Suman, Al Malki, Monzr M., Larson, Richard A., Asch, Adam S., Mannis, Gabriel, Chai-Ho, Wanxing, Tanaka, Tiffany N., Bradley, Terrence J., Jeyakumar, Deepa, Wang, Eunice S., Sweet, Kendra, Kantarjian, Hagop M., Garcia-Manero, Guillermo, Komrokji, Rami, Xing, Guan, Ramsingh, Giridharan, Renard, Camille, Zeidner, Joshua F., Sallman, David A.
Publicado 2023